Although orbital exenteration has been recommended for extensive malignant conjunctival neoplasms, including those invading the palpebral margin, fornices, or caruncle, it has not been demonstrated to improve survival of patients with melanomas greater than 2.0 mm thick.1 We describe a patient with extensive conjunctival melanoma (CM) managed by eye-preserving therapies.
Article InformationCorresponding Author: Zélia M. Corrêa, MD, PhD, Department of Ophthalmology, University of Cincinnati College of Medicine, 260 Stetson St, Ste 5300, Cincinnati, OH 45267 (email@example.com).
Published Online: August 28, 2014. doi:10.1001/jamaophthalmol.2014.2871.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was supported in part by an unrestricted grant from Research to Prevent Blindness (Dr Augsburger).
Role of the Funder/Sponsor: Research to Prevent Blindness had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.